| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Veterinary Pathology, Vol 16, Issue 6 635-649, Copyright © 1979 by American College of Veterinary Pathologists
ARTICLES |
H. J. Baker, G. D. Reynolds, S. U. Walkley, N. R. Cox and G. H. Baker
Ganglioside storage diseases are inherited defects of lysosomal hydrolases that result in intralysosomal accumulation of gangliosides and other complex metabolites. Gangliosidoses occur in man, cats, cattle, dogs and swine. In all species, these diseases are characterized clinically by relentlessly progressive neurological deterioration. Lysosomal hypertrophy with characteristic ultrastructural inclusions occur in neurons, endothelial and other cells. Definitive diagnosis requires biochemical identification of the storage product and enzyme deficiency. Gangliosidoses in animals are important models of human lysosomal diseases and may be a significant complication in the maintenance of certain purebred stocks of domestic animals.
This article has been cited by other articles:
![]() |
G. Muller, S. Alldinger, A. Moritz, A. Zurbriggen, N. Kirchhof, A. Sewell, and W. Baumgartner GM1-gangliosidosis in Alaskan Huskies: Clinical and Pathologic Findings Vet. Pathol., May 1, 2001; 38(3): 281 - 290. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. R. Cox, N. E. Morrison, J. L. Sartin, F. C. Buonomo, B. Steele, and H. J. Baker Alterations in the Growth Hormone/Insulin-Like Growth Factor I Pathways in Feline GM1 Gangliosidosis Endocrinology, December 1, 1999; 140(12): 5698 - 5704. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |